Skip to main content
Clinical and Translational Gastroenterology logoLink to Clinical and Translational Gastroenterology
. 2018 Jul 31;9(7):172. doi: 10.1038/s41424-018-0040-5

Correction: Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants

Michael G Kattah 1,✉, Jeffrey M Milush 2, Trevor Burt 3, Robert P McCabe Jr 4, Michael I Whang 1, Averil Ma 1, Uma Mahadevan 1
PMCID: PMC6068199  PMID: 30065242

Correction to: Clinical and Translational Gastroenterology 10.1038/s41424-018-0018-3; published online 3 April 2018

The original version of this article contained an error in Fig. 2, in which part of the text in the legend was omitted. Figure 2 legend should read “Fig. 2. Infants exposed to combination therapy with an anti-TNF agent and an immunomodulator exhibited a trend toward reduced CD27+ B cells, switched memory B cells, plasmablasts, IFNγ-producing CD4+ and CD8+ T cells, and CD4+ CCR5+ T cells, which did not reach statistical significance. a Ranked p-values for cell subsets in the three-group analysis comparing CZP vs IFX/ADA vs IFX/ADA + IM. b–g Median, interquartile ranges, and ranges of frequencies of each cell subset, expressed as a percent of the parent population, are shown. The p-value and q-value displayed in b–g were calculated in the three-group analysis. KW Kruskal–Wallis.”

Furthermore, the figure legends were missing for the Supplementary figure files. The HTML has now been updated to include a corrected version of the Supplementary Information.


Articles from Clinical and Translational Gastroenterology are provided here courtesy of American College of Gastroenterology

RESOURCES